The tweet was deleted by the author.
But we saved everything 🙂.
Avalanche (AVAX) is currently trading at $8.20, representing a daily drop of $0.53 or 6.04% compared to the previous close. Intraday, AVAX has moved lower by $0.40 or 4.65% since the market opened, with price action pushing towards the session lows amid strong selling pressure. Today's decline is primarily attributed to persistent technical weakness, reflected by the price falling below both the 20-day and 50-day moving averages, as well as a broad loss of momentum despite recent positive headlines. The market's focus remains on bearish signals and volatility, outweighing optimism from institutional partnership news.
Emin Sirer highlighted Avalanche’s early recognition of the need for a scalable, unique blockchain infrastructure, suggesting the industry is catching up to its vision. This tweet was intended to reinforce confidence in Avalanche’s long-term adoption prospects and its suitability for major financial projects, which could enhance demand and institutional sentiment for AVAX. However, despite the positive signal from Sirer, the market is currently reacting more to weak technicals and profit-taking after recent speculative gains. At the same time, news of the NYSE’s planned use of Avalanche’s blockchain as a settlement layer for tokenized securities has drawn attention to the platform’s potential for traditional finance, though direct effects on AVAX demand remain unclear.
View post on X Loading...
AVAX is trading below the MA-20 at $8.69 and MA-50 at $9.82, but remains just above the MA-200 at $8.12, signaling short-term and medium-term bearish pressure with only tentative long-term support. Immediate support is seen at $8.12, while resistance stands at $9.15 on the daily chart. The dominant signal from MACD, RSI, and related indicators is bearish momentum, with little evidence of a reversal. The 5-day outlook projects trading between $7.38 and $8.60, with downside dominant and the positive fundamental narrative from Sirer not yet confirmed by price action, warranting caution in the near-term forecast.
Previously it was reported that Avalanche's major NYSE partnership raised questions about the direct benefit to AVAX despite the scale of the deal. This article examines how current developments impact Avalanche, highlighting the need to monitor upcoming regulatory milestones as a potential catalyst for renewed price momentum.